Investors / Pivotal Life Sciences / Compare with RA Capital

Pivotal Life Sciences vs RA Capital

Pivotal Life Sciences lists 33 portfolio companies and has joined 5 funding rounds; RA Capital lists 217 companies and has joined 64 rounds. Pivotal Life Sciences comes in most often at Series A (60% of its entries), RA Capital comes in most often at Growth (39% of its entries). 10 companies are on both portfolios, among them Arcutis, BioAge Labs and Bolt Biotherapeutics.

Pivotal Life SciencesView profilevsRA CapitalView profile

33Portfolio companies217

5Funding rounds joined64

1Rounds led25

4Rounds, last 12 months46

$100M or moreTypical round it comes in at$100M or more

0%Sites no longer answering0%

Show as a table

Pivotal Life Sciences and RA Capital, head to head

	Pivotal Life Sciences	RA Capital
Portfolio companies	33	217
Funding rounds joined	5	64
Rounds led	1	25
Rounds, last 12 months	4	46
Typical round it comes in at	$100M or more	$100M or more
Sites no longer answering	0%	0%

Companies both back

10

Arcutisarcutis.comBioAge Labsbioagelabs.comBolt Biotherapeuticsboltbio.comEstuary Bioestuarybio.comEvommuneevommune.comIO Biotechiobiotech.comObsidian Therapeuticsobsidiantx.comParabilis Medicinesparabilismed.comVaxcytevaxcyte.comWindward Biowindwardbio.com

Shared companies are those both firms' own portfolio pages list, each checked against the company's site. The same comparison through the API is POST /v1/overlap, for up to 20 firms. How the data is graded

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/pivotallifesciences.com/portfolio

# also
GET /v1/firms/racap.com/portfolio
GET /v1/firms/pivotallifesciences.com/coinvestors